Avatrombopag Maleate, identified by its CAS Registry Number 677007-74-8, stands as a pivotal active pharmaceutical ingredient (API) in modern medicine. This compound is widely recognized as a highly effective thrombopoietin (TPO) receptor agonist, playing a crucial role in managing specific blood disorders. NINGBO INNO PHARMCHEM CO.,LTD. is proud to offer this high-quality compound, ensuring its availability for diverse pharmaceutical needs.

The primary function of Avatrombopag Maleate revolves around its unique mechanism of action. It acts by specifically targeting and activating the thrombopoietin receptor. This activation leads to the stimulation of megakaryocytopoiesis, the process by which bone marrow produces megakaryocytes. These large cells are responsible for generating platelets, which are essential for blood clotting and preventing excessive bleeding. By increasing the production of megakaryocytes, Avatrombopag Maleate effectively raises platelet levels in the blood, addressing conditions characterized by low platelet counts.

Avatrombopag Maleate is primarily indicated for the treatment of thrombocytopenia, a condition defined by abnormally low platelet levels. Its therapeutic utility spans two significant areas. Firstly, it is used in adult patients with chronic liver disease who are scheduled to undergo various medical or dental procedures. In such cases, a low platelet count significantly increases the risk of bleeding during interventions. Avatrombopag Maleate helps to pre-emptively boost platelet counts, thereby minimizing hemorrhagic complications. Secondly, it is prescribed for adults suffering from chronic immune thrombocytopenia (ITP), particularly when other conventional treatments have proven insufficient. In both applications, the goal is to raise and maintain platelet levels to a safe threshold, thereby enhancing patient safety and quality of life.

One of the key advantages of Avatrombopag Maleate is its oral activity, making it a convenient treatment option for patients. It is not intended as a cure but rather as a highly effective means to manage and normalize platelet counts, significantly reducing the risk of bleeding. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its Avatrombopag Maleate consistently meets stringent quality standards, offering a product with an assay of more than 99% purity. Our commitment to excellence in manufacturing means that this API is produced under rigorous quality control, aligning with global pharmaceutical best practices such as GMP, FDA, and ISO certifications.

As a dedicated manufacturer and supplier of advanced pharmaceutical chemicals, NINGBO INNO PHARMCHEM CO.,LTD. is well-positioned to meet the global demand for Avatrombopag Maleate. We maintain a reliable production capacity to ensure consistent supply for our clients worldwide. Our focus is on providing high-quality APIs at a competitive price, making essential medications more accessible. For those looking to buy Avatrombopag Maleate, we offer flexible supply options, from grams to kilograms, to accommodate varying research and production needs. We encourage prospective clients to reach out for detailed pricing information and to discuss their specific purchase requirements. Our team is committed to facilitating smooth transactions and establishing long-term, mutually beneficial partnerships. Choosing NINGBO INNO PHARMCHEM CO.,LTD. means partnering with a company dedicated to quality, reliability, and customer satisfaction in the pharmaceutical chemical industry.